EP0879889A3 - Ein Glied von Interleukin-1 Familie, iL-1 delta - Google Patents

Ein Glied von Interleukin-1 Familie, iL-1 delta Download PDF

Info

Publication number
EP0879889A3
EP0879889A3 EP98301169A EP98301169A EP0879889A3 EP 0879889 A3 EP0879889 A3 EP 0879889A3 EP 98301169 A EP98301169 A EP 98301169A EP 98301169 A EP98301169 A EP 98301169A EP 0879889 A3 EP0879889 A3 EP 0879889A3
Authority
EP
European Patent Office
Prior art keywords
disease
delta
polypeptides
polynucleotides
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98301169A
Other languages
English (en)
French (fr)
Other versions
EP0879889A2 (de
Inventor
Peter R. Young
Ian E. James
Janice R. Connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0879889A2 publication Critical patent/EP0879889A2/de
Publication of EP0879889A3 publication Critical patent/EP0879889A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
EP98301169A 1997-05-19 1998-02-17 Ein Glied von Interleukin-1 Familie, iL-1 delta Withdrawn EP0879889A3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4695797P 1997-05-19 1997-05-19
US46957P 1997-05-19
US08/939,300 US5945310A (en) 1997-05-19 1997-09-29 DNA encoding members of the IL-1 family, IL-1 delta
US939300 2001-08-24

Publications (2)

Publication Number Publication Date
EP0879889A2 EP0879889A2 (de) 1998-11-25
EP0879889A3 true EP0879889A3 (de) 2000-11-02

Family

ID=26724477

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98301169A Withdrawn EP0879889A3 (de) 1997-05-19 1998-02-17 Ein Glied von Interleukin-1 Familie, iL-1 delta

Country Status (4)

Country Link
US (1) US5945310A (de)
EP (1) EP0879889A3 (de)
JP (2) JPH11177A (de)
CA (1) CA2221866A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205381B2 (en) 1997-04-21 2007-04-17 Schering Corporation Mammalian cytokines; related reagents and methods
US6426191B1 (en) * 1998-04-03 2002-07-30 Hyseq, Inc. Assays involving an IL-1 receptor antagonist
ATE349526T1 (de) * 1999-05-25 2007-01-15 Immunex Corp Il-1 eta dna und polypeptide
JP2004500028A (ja) * 1999-06-10 2004-01-08 ディジタル・ジーン・テクノロジーズ・インコーポレーテッド 胃腸炎における遺伝子発現調節
US6346247B1 (en) 1999-10-28 2002-02-12 Promega Corporation Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
MXPA02005731A (es) * 1999-12-10 2003-10-14 Amgen Inc Moleculas similares al antagonista del receptor de interleucina-1 y usos de las mismas.
JP2003516735A (ja) * 1999-12-10 2003-05-20 アムジェン インコーポレイテッド インターロイキン−１レセプターアンタゴニスト様分子およびその使用
US6818444B2 (en) * 2000-08-04 2004-11-16 Heska Corporation Canine and feline proteins, nucleic acid molecules and uses thereof
BR0315155A (pt) * 2002-10-08 2005-08-16 Ares Trading Sa Uso de citocina capaz de ligar il-18bp e de inibir a atividade de uma segunda citocina
WO2006084145A2 (en) * 2005-02-02 2006-08-10 Regeneron Pharmaceuticals, Inc. Methods of using il-1 antagonists to reduce c-reactive protein
WO2007034465A2 (en) * 2005-09-21 2007-03-29 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Use of il-1f5 for the modulation of an immune-mediated response
AU2006330410A1 (en) * 2005-12-28 2007-07-05 Centocor, Inc. Markers and methods for assessing and treating psoriasis and related disorders
CN103608030A (zh) * 2011-06-21 2014-02-26 昂科发克特公司 用于治疗和诊断癌症的组合物和方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C.A. DINARELLO: "The Interleukin-1 family: 10 years of discovery", FASEB JOURNAL., vol. 8, December 1994 (1994-12-01), FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD., US, pages 13141325, XP002145619, ISSN: 0892-6638 *
DINARELLO C A: "BIOLOGIC BASIS FOR INTERLEUKIN-1 IN DISEASE", BLOOD,US,W.B. SAUNDERS, PHILADELPHIA, VA, vol. 87, no. 6, 15 March 1996 (1996-03-15), pages 2095 - 2147, XP000574933, ISSN: 0006-4971 *
YOUNG P.R. ET AL: "Identification and initial characterization of four novel members of the interleukin-1 family", JOURNAL OF BIOLOGICAL CHEMISTRY., vol. 275, 7 April 2000 (2000-04-07), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD., US, pages 10308 - 10314, XP000938731, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
EP0879889A2 (de) 1998-11-25
US5945310A (en) 1999-08-31
JPH11177A (ja) 1999-01-06
CA2221866A1 (en) 1998-11-19
JP2000083688A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
EP0870827A3 (de) Tumor-Nekrosis-Faktor verwandter Receptor, TR6
EP0879889A3 (de) Ein Glied von Interleukin-1 Familie, iL-1 delta
EP0855444A3 (de) Aspartat-Proteinase 2 (ASP2)
CA2189526A1 (en) Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
CA2096911A1 (en) Amyloid precursor protein protease
AU3318793A (en) Diagnostic assay for Alzheimer's Disease based on the proteolysis of Alzheimer's precursor protein
EP0848062A3 (de) Aspartylprotease ASP1
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
EP0897002A3 (de) U62317, ein Protein mit einem JNK-bindendem Gebiet
EP0867509A3 (de) Tumornekrosis bezohener Rezeptor, TR5
CA2189527A1 (en) Novel Elastase Inhibitors
CA2192675A1 (en) Methods for treating motor deficits
EP1179588A4 (de) Menschliche gehirn-spezifische carboxypeptidase
EP0887406A3 (de) Ein Mitglied der FRZB-Familie, Frazzled
EP0894855A3 (de) Menschlicher I kappa B-beta Transkriptionsfaktor
EP0875577A3 (de) Gen der Membrantyp-Matrix-Metalloproteinase-5
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
EP0875572A3 (de) CRFG-1a, Ziel und Marker für chronisches Nierenversagen
EP0913472A3 (de) Humanes LIG-1 Homologes (HLIG-1)
WO2000075280A3 (en) A member of the frzb family, frazzled
EP0897009A3 (de) HKABY60 Polypeptide
EP0874050A3 (de) Integrinligand ITGL-TSP
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
WO1998042833A3 (en) Kv potassium channel polypeptides and polynucleotides
WO2001023587A3 (en) Serine protease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE DK FR GB IT LI NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010502

AKX Designation fees paid

Free format text: BE CH DE DK FR GB IT LI NL

17Q First examination report despatched

Effective date: 20020926

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030408